ZevDavid(Schuman)Schuman-OlivierMD

Addiction, Integrative Psychiatry

Instructor in Psychiatry, Harvard Medical School, Cambridge Health Alliance; Adjunct Assistant Professor, Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth

Join to view full profile

Dr. Schuman-Olivier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schuman-Olivier's full profile

Already have an account?

Office
1493 Cambridge St
Cambridge, MA 02139
Phone+1 617-575-5456

Education & Training

Massachusetts General Hospital/McLean Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Addiction Psychiatry, 2009 - 2011
Cambridge Health AllianceResidency, Psychiatry, 2005 - 2009
Tufts University School of MedicineClass of 2005

Certifications & Licensure

MA State Medical License 2007 - 2026
NH State Medical License 2012 - 2024
FL State Medical License 2013 - 2023
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers Start of enrollment: 2011 Jan 01
Unknown status
Not Applicable
MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence Start of enrollment: 2017 Mar 24
Completed
Not Applicable
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE) Start of enrollment: 2016 Nov 01
Completed
Not Applicable
MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home Start of enrollment: 2015 Oct 01
Completed
Not Applicable
Mindful Self-Regulation fMRI Pilot Study Start of enrollment: 2016 Sep 01
Completed
Not Applicable
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2) Start of enrollment: 2017 Feb 01
Completed
Not Applicable
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 3) Start of enrollment: 2019 Jan 30
Terminated
Not Applicable
Mindful Self-Regulation fMRI Study (MindfulPCfMRI) Start of enrollment: 2019 Jan 30
Terminated
Not Applicable
MINDFUL-PC for Portuguese Speakers Pilot Study 2020 Start of enrollment: 2020 Jan 21
Terminated
Not Applicable
Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study Start of enrollment: 2020 Jul 13
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

70 citations
Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers
Zev Schuman-Olivier, Mark J. Albanese, Sarah E. Nelson, Lolita Roland, Francyne Puopolo
Journal of Substance Abuse Treatment. 2010-07-01
922 citations
How Does Mindfulness Meditation Work? Proposing Mechanisms of Action From a Conceptual and Neural Perspective
Britta K. Hölzel, Sara W. Lazar, Tim Gard, Zev Schuman-Olivier, David R. Vago
Perspectives on Psychological Science. 2011-10-14
15 citations
Mindfulness Training Improves Quality of Life and Reduces Depression and Anxiety Symptoms Among Police Officers: Results From the POLICE Study-A Multicenter Randomized...
Marcelo Trombka, Marcelo Marcos Piva Demarzo, Daniel Campos, Sonia Beira Antonio, Karen Cicuto
Frontiers in Psychiatry. 2021-01-01

Press Mentions

Addiction Treatment Gap Is Driving A Black Market for SuboxoneOctober 5th, 2018
There's an Illegal Market for an Opioid Addiction Medication. Is That Such A Bad Thing?September 3rd, 2018
Study Links Opioid Deaths to Workplace InjuriesAugust 8th, 2018